MHRA delivers its targets to increase access to medicines and reinforce UK position as a global destination for life sciences

The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.